These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Treatment of liver cirrhosis and chronic liver diseases with total liver extract]. Borgo E Minerva Med; 1965 Nov; 56(88):3735-9. PubMed ID: 5846626 [No Abstract] [Full Text] [Related]
5. [Trial of LL 650 in various hepatic diseases]. Savoye B; Dietsch R; Chapuy M; Girard M J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113 [No Abstract] [Full Text] [Related]
6. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases]. Kleine FD Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281 [No Abstract] [Full Text] [Related]
7. [Therapeutic effects of hepason in liver oirrhosis]. Grala R; Adamski A; Kretschmer R Pol Tyg Lek; 1965 Apr; 20(14):523-5. PubMed ID: 5836380 [No Abstract] [Full Text] [Related]
8. [Clinical experience in the treatment of chronic liver diseases with Solcohepsyl extralysate]. Arias Vallejo E Folia Clin Int (Barc); 1966 Sep; 16(9):404-15. PubMed ID: 5990974 [No Abstract] [Full Text] [Related]
9. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases]. Pignattari S; Sarti F; Toscano S; Dal Monte PR Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878 [No Abstract] [Full Text] [Related]
10. [The treatment of compensated hepatopathies using Sirepar and Ripason]. Fassati P; Fassati M Cas Lek Cesk; 1967 Oct; 106(43):1143-50. PubMed ID: 6077099 [No Abstract] [Full Text] [Related]
11. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis]. Bakulenko EF Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172 [No Abstract] [Full Text] [Related]
12. [On the action of a total liver extract in subacute and chronic hepatopathies]. Bazzicalupo G; Coscelli C Minerva Med; 1968 Sep; 59(76):3977-82. PubMed ID: 5698739 [No Abstract] [Full Text] [Related]
13. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases]. Pasotti C; Buniva G; Carpinella G Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990 [No Abstract] [Full Text] [Related]
14. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases. Obayashi A; Akioka H; Tazaki H Arzneimittelforschung; 1972 Mar; 22(3):578-80. PubMed ID: 5067932 [No Abstract] [Full Text] [Related]
15. [Enzymatic therapy in hepatology with ornithine carbamol transferase]. Monges H; Hancy A; Codinach N Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506 [No Abstract] [Full Text] [Related]
16. [Use of "Essenciale" in the treatment of liver diseases]. Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064 [No Abstract] [Full Text] [Related]
18. [Therapy of liver diseases, possibilities and problems]. Renger F Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481 [No Abstract] [Full Text] [Related]
19. The treatment of chronic liver diseases by means of an extralysate of liver. Kallai L; Kocić J Arzneimittelforschung; 1969 Jun; 19(6):1030-1. PubMed ID: 5820032 [No Abstract] [Full Text] [Related]
20. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis]. Ravazzoni C; Balzano E; Cuneo S Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918 [No Abstract] [Full Text] [Related] [Next] [New Search]